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The sarA locus in Staphylococcus aureus controls the expression of
many virulence genes. The sarA regulatory molecule, SarA, is a
14.7-kDa protein (124 residues) that binds to the promoter region
of target genes. Here we report the 2.6 Å-resolution x-ray crystal
structure of the dimeric winged helix SarA protein, which differs
from the published SarA structure dramatically. In the crystal
packing, multiple dimers of SarA form a scaffold, possibly via
divalent cations. Mutations of individual residues within the DNA-
binding helix–turn–helix and the winged region as well as within
the metal-binding pocket implicate basic residues R84 and R90
within the winged region to be critical in DNA binding, whereas
acidic residues D88 and E89 (wing), D8 and E11 (metal-binding
pocket), and cysteine 9 are essential for SarA function. These data
suggest that the winged region of the winged helix protein
participates in DNA binding and activation, whereas the putative
divalent cation binding pocket is only involved in gene function.
S taphylococcus aureus is a versatile bacterium capable ofcausing a wide spectrum of human infections, ranging from
superficial abscesses to pneumonia, endocarditis, and sepsis (1,
2). This versatility may be attributable to the impressive array of
extracellular and cell wall-associated virulence determinants
coordinately expressed during the infectious process (3). Many
of these virulence factors are either secreted or cell surface-
associated proteins. Secreted proteins such as hemolysins, lipase,
and proteolytic enzymes are responsible for invasion and tissue
damage. Cell surface-associated proteins such as protein A and
fibronectin-binding proteins mediate adhesion to host tissues
(4). The coordinate expression of many virulence determinants
in S. aureus has been shown to be regulated by global regulatory
elements such as staphylococcal accessory regulator (sarA) and
accessory global regulator (agr) (5, 6). These regulatory ele-
ments, in turn, control the transcription of a wide variety of
unlinked genes, many of which have been implicated in patho-
genesis. Transcription profiling study showed that an agr muta-
tion could alter the expression of 138 genes, with 104 up-
regulated and 34 down-regulated, whereas a sarA mutation leads
to altered expression of 120 genes, with 76 and 44 genes
up-regulated and down-regulated, respectively (7).
The sarA locus has been shown to promote the synthesis of
selected extracellular and cell wall-associated proteins while
repressing the transcription of the protein A and protease genes
(8). The sarA locus is composed of three overlapping transcripts,
sarA P1, sarA P3, and sarA P2, each encoding the major 372-bp
sarA ORF that yields the 14.7-kDa SarA protein (5). DNase I
footprinting studies revealed that the SarA protein binds to
several target gene promoters (9), including those of agr, hla, spa,
and fnbA, thus implicating SarA to be a DNA-binding protein
that can modulate target gene transcription via both agr-
dependent and agr-independent pathways (9–12).
SarA is the first member of the SarA protein family that has
been found to play vital roles in the regulation of virulence genes.
A search of the recently released S. aureus genomes revealed at
least 10 additional SarA homologs, six of which have been
partially characterized. These members include SarR, SarS,
SarT, SarU, SarV, and MgrA (also called Rat) (12–16). Members
of the SarA protein family also share sequence homology with
the MarR protein or homologs in Gram-negative bacteria (13).
Schumacher et al. (17) have reported the SarA structure as well
as cocrystallization data with an 8-bp agr promoter sequence.
Based on the reported structures, they proposed a ‘‘shortening’’
effect of DNA as a result of binding by the dimeric SarA protein,
leading to gene activation (17). Independently, we reported the
dimeric SarR structure to be a typical ‘‘winged-helix DNA-
binding protein’’ in the absence DNA, with the helix–turn–helix
(HTH) and the winged regions interacting with the major and
minor grooves of target promoter DNA, respectively (18). We
also proposed the two conserved acidic patches on the convex
side of the SarR structure as possible functional motifs, whereas
the concave surface, containing a tract of basic residues, is likely
to be the DNA-binding side (18). Based on sequence alignment,
we speculated SarR, SarA, SarS, and possibly other MarR
homologs to have similar folds, which are strongly supported by
the structure of SarS (13, 19); however, these structures diverge
significantly from the reported SarA structure with a completely
different topology. Additionally, despite low sequence homol-
ogy, the reported MarR structure has similar topological folds as
the SarR and SarS proteins, consistent with our structural and
sequence alignment predictions (20). To resolve the discrepancy
between the reported SarA and SarR structures and to under-
stand the structure-function relationship of SarA, we indepen-
dently determined the SarA structures in two crystal forms and
found it to be also a winged helix protein. Mutagenesis analysis
of single and selected double residues that are conserved within
the SarA protein family indicated that the basic residues within
the winged region are important for DNA binding, whereas the
acidic residues within the wing and a putative divalent cation
binding pocket are involved in SarA function. These findings
confirm the structural prediction of the SarA crystal structure.
Results
Overall Structure of SarA. The structure of the SarA protein
reported here has a similar topology to structures of SarR and
SarS (Fig. 1; refs. 18 and 19). Briefly, there is one homodimer of
SarA in one asymmetric unit, which is the assumed basic
functional unit. The monomeric SarA structure consists mainly
of five -helices and three -strands. 1-helices from both
monomers are the major components that bring the two mono-
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mers together. The dimer association surface is highly hydro-
phobic and conserved among the family members. 3 and 4
build up the typical HTH motif, a widely existing protein scaffold
for transcription factors accounting for DNA binding. Two of the
three total antiparallel -strands (1, 2, and 3), 2 and 3,
form the beta hairpin (the wing), which is predicted to interact
with the minor groove of target DNA (18). The overall rms
deviation between SarA and SarR is 2.5 Å. Individual compar-
ison of the two winged helical motifs yields an even smaller
difference (1.9 Å). The two 5-helices from each monomer are
longer than those of the SarR in the C termini. Big differences
are found at the two -hairpin regions, which are the flexible
pro-DNA binding regions of SarR (18) but are well defined in the
SarA structure. Interestingly, the SarA structure reported here
differs significantly from those of SarA reported by Schumacher
et al. (ref. 17; with and without DNA bound, PDB ID codes
1FZN and 1FZP, Figs. 6 and 7, which are published as supporting
information on the PNAS web site), except for three helical
regions (1, 4, and part of 5). Two helices (2 and 3) are
completely absent in the reported SarA structures and the 
hairpin motif is missed in the complex structure of SarA and
DNA (17). An additional extended helix exists in the C-terminal
of the reported SarA structures (17).
Two half-calcium ions were found at the N termini of the two
SarA monomers, which are shown strongly on a 2Fc  Fo map
with eight-sigma level (Fig. 8, which is published as supporting
information on the PNAS web site). Three residues from one
monomer of one dimer and three correspondent residues from
another monomer of a neighboring dimer related by crystallo-
graphic symmetry are involved in the coordination for each
calcium ion (Fig. 2A). Residue Glu-11 is located at the beginning
of helix  1. Residue Asp-8 is on the short coil that is antiparallel
to the corresponding coil strand from the other monomer (Fig.
2A). The side chain of Asn-7 also takes part in the coordination
of the calcium ion through the proper orientation of the carboxyl
group. Six residues from two monomers build up a standard
chelating site for one Ca2 (Fig. 2 A). Notably, each Ca2 brings
two SarA dimers together through a crystallographic symmetry
relation (61) (Fig. 2B). Three or more SarA dimers stack up and
generate a super helix with the putative DNA-binding surface
located at the outer side and calcium binding sites inside (Fig.
2B). This type of oligomerization raises the question whether
SarA functions as dimer alone or multiple dimers, with the aid
of divalent cations. The prediction will be that mutation of Asp-8
Fig. 1. Structures of the SarA dimer, side chains of residues that involve in
Ca2 binding are shown on the convex side of the SarA dimer. The assumed
DNA-binding surface is opposite of Ca2-binding sites. Two -hairpins (2 and
3 from monomer one, and those from monomer two) two HTH motifs (3
and 4 from monomer one, and those from another monomer) build up the
putative DNA-binding surface on the concave side of the SarA dimer. All
structural model figures are made by program RIBBONS (21).
Fig. 2. The positions of Ca2 and their association with multiple dimers of the
SarA. (A) Detailed side chains of residues that involve Ca2 binding are shown
from both dimer of SarA; calcium ions are colored purple. (B) The association
of dimers of SarA through Ca2; three SarA homodimers are involved through
an x-ray axis (61).









and Glu-11 would render SarA nonfunctional in complementa-
tion (see below).
Alignment of SarA Homologs and Mutagenesis Studies of Conserved
Residues Within the Winged Helix Regions. In superimposing the
secondary structure of SarA with the alignment of several SarA
homologs (SarA, SarR, SarT, MarR, and the N-terminal half of
SarS), we have found the following: (i) conserved basic residues
within the 3-4 HTH; (ii) conserved basic and acid residues
within 2-L-3 winged region, with DER (residues 88–90)
highly conserved among the SarA family members; (iii) semi-
conserved acidic residues (D8 and E11) at the divalent metal
binding pocket; (iv) unique cysteine residue at position 9; and (v)
conserved residues within the SarA homologs, including L40,
L74, Q100, and I104 (Fig. 3A). To obtain mutated SarA protein
with alanine substitutions at corresponding residues, the intact
375-bp gene was mutated, cloned in frame into the NdeIBamHI
sites of pET14b, expressed in BL21, and purified separately over
a nickel resin affinity column. Most of the mutant proteins were
successfully expressed and purified to homogeneity. A 160-bp
promoter fragment of the protein A gene (spa), a known SarA
binding target (11), was used in gel shift assays to determine the
binding of the mutant SarA proteins. SarA proteins with K21A,
K28A, K69A, K82A, D88A, and E89A mutations (Fig. 3B) and
D8A, E11A, C9A, K23A, L40A, K27A, and K63A mutations
(data not shown) were able to bind to the spa promoter in a
manner similar to the wild-type protein. Mutations of C9, Y18,
E29, E36A, K54, L74, and F80 to alanine reduced the binding of
protein to the spa promoter (Fig. 3B). Remarkably, two mutant
SarA proteins with R84A and R90A mutations failed completely
to bind to the spa promoter, thus indicating the importance of
these two residues within the winged region (Fig. 3A) in binding
to the target promoter. Interestingly, among the highly con-
served DER residues within the loop of the winged region (13),
only R90 is essential to DNA binding. In addition, R84, residing
within 2 strand that also constituted part of the wing, is also
critical to binding. A double E89A-R90A mutation in SarA also
failed to bind to the spa promoter, thus confirming that E89
likely did not contribute to binding.
To ascertain the effect of these mutations on target genes, we
chose to evaluate the transcription of sarA-regulated genes in
sarA mutants containing shuttle plasmids (pSK236) with muta-
tions at various codon positions. Because the sarA locus contains
three transcripts, we elected to simplify our interpretation by
using the strongest and the most proximal sarA P1 promoter to
drive wild-type or mutant sarA gene. To ensure that the sarA
mutant genes were expressed, we first examined the sarA P1
transcription in sarA mutant strains. As shown in Fig. 4A, all
clones were able to express sarA P1 transcription. Immunoblot
studies with anti-SarA monoclonal antibody 1D1 also confirmed
that, with the exception of the L40A mutation, which likely
rendered the SarA protein insoluble (unpublished observation),
the sarA mutant clones, upon complementation, were able to
express the mutant SarA proteins, whereas the sarA mutant
negative control ALC488 did not (Fig. 4B). To evaluate sarA
target genes, we chose to examine two genes, spa and aur
(aureolysin gene), normally repressed by a functional SarA
molecule. As expected, the transcription of spa and aur was
elevated in the sarA mutant ALC488 but not in the mutant
complemented with the wild type sarA gene. Interestingly, sarA
mutant clones, expressing mutant SarA proteins (Y18, E29,
E36A, K54, L74, and F80) that exhibited reduced binding to the
Fig. 3. Mutations and analyses of SarA residues conserved in the SarA
protein family. (A) The primary sequence alignment of SarA, SarR, SarT, SarS1
(1–125 residues of SarS), and MarR superimposed with the secondary struc-
tures of SarR and SarA proteins of S. aureus (17). Numbers at the beginning of
each line indicate amino acid positions relative to the start of each protein
sequence. Helices are indicated by , -sheets are indicated by , and loops and
turns are marked by L. The residues () altered by mutagenesis have been
highlighted. (B) Autoradiogram of a nondenaturing 8% PAGE showing the
binding of the wild-type and the mutant forms of SarA to a 160-bp spa
promoter fragment. Lanes 1–4 correspond to 0 ng, 100 ng, 300 ng, and 500 ng
of wild-type SarA or the mutant SarA as indicated on the lanes, with 0.1 ng of
a -32P-labeled 160-bp DNA fragment used for each lane in the binding
reaction.
Fig. 4. Effects of sarA mutations at various codon positions in in vivo
expression of target genes. (A) Northern blots of RNA isolated from isogenic
sarA mutant ALC488, and ALC488 constructs containing shuttle plasmid with
the wild-type and mutated sarA fragments at postexponential phases (OD650
1.7 with 18-mm borosilicate glass tubes by using spectrophotometer Spec-
tronic 20). A total of 10 g of cellular RNA was loaded onto each lane. The blots
were probed with 375-bp sarA (Top), 1,200-bp spa (Center Top), 1,500-bp aur
(Center Bottom), and 724-bp of 16S rRNA (Bottom; nucleotides 777-1,500 of
GenBank accession no. X68417) gene fragments. (B) Western blots of intra-
cellular extract were probed with monoclonal anti-SarA antibody 1D1. Equiv-
alent amounts of extracts (5 g each) from the same growth conditions were
used to detect SarA expression.
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spa promoter (Fig. 3), did not display any functional deficit with
respect to spa and aur repression. For two constructs expressing
mutant SarA proteins (R84A and R90A) that failed to bind to
the spa promoter, these clones, expectedly, did not repress
transcription of spa and aur. Of interest are the D88A and E89A
mutations within the highly conserved DER motifs within the
SarA and the MarR protein families (13); mutant clones ex-
pressing these proteins bound spa promoter normally (Fig. 3) but
did not complement the sarA mutant phenotype with respect to
spa and aur as compared with the nonmutated wild-type control.
Besides examining D88A and E89A mutations, we also mutated
the unique cysteine residue of SarA and the less-conserved lysine
residue (K23) within the 1 helix to alanine. Although the C9A
mutant SarA protein bound well to the spa promoter, the sarA
fragment with this mutation did not restore repression of the spa
and aur genes in the sarA mutant, thus indicating that the unique
cysteine residue (9C), adjacent to the divalent cation binding
pocket, plays a role in SarA function. Additionally, a K23A
mutation that yielded normal binding protein also failed to
complement the spa and aur genotype in a sarA mutant. Because
the 1 helix is involved in dimerization of two SarA monomers,
the possibility of a dimerization defect in the K23A mutant has
not been defined.
The Role of the Residues Within the Divalent Cation Binding Pocket in
SarA Function. In the crystal structure of SarA, we have observed
the involvement of divalent cations in linking SarA dimers. The
three residues that are involved in Ca2 binding (Asn-7, Asp-8,
and Glu-11) were conserved among SarA, SarR, and part of
SarS, with occasional conserved substitution of Glu-11 by Asp,
but not in SarT and other members. This observation raises the
question whether the two negatively charged residues that
constitute the putative calcium-binding sites are required for
SarA function. To address this question, two point mutations
within SarA were generated by replacing residues Glu-11 and
Asp-8 with alanines. The shuttle plasmid containing the wild-
type or the mutated sarA gene was introduced into sarA mutant
ALC488. Northern blots with a sarA probe revealed transcrip-
tion of the native and mutated sarA genes (data not shown).
Immunoblot analysis disclosed that both the intact and mutated
SarA proteins were expressed in the sarA mutant construct (Fig.
5B). However, the amount of the mutated SarA protein was less
than that of the nonmutated control but higher than the parental
strain carrying a single copy of the sarA gene (Fig. 5B). DNA-
binding assays with purified intact SarA and mutant SarA
protein (D8A-E11A) and an 180-bp agr promoter fragment
disclosed that the mutated SarA protein retained DNA-binding
properties similar to that of the native protein (Fig. 5C).
Transcriptional analysis disclosed that the mutated gene (D8A
and E11A) did not complement the sarA genotype and pheno-
type in the sarA mutant with respect to restoring agr RNAII and
-hemolysin gene transcription and repressing spa expression,
whereas the nonmutated sarA gene did (Fig. 5 A and B). These
data confirmed that D8 and E11 within the putative divalent
cation-binding pocket are essential to SarA function.
Discussion
The Discrepancy Between Two SarA Structures. Several lines of
evidence suggest that the SarA structure reported here repre-
sents the native form of SarA. First, sequence alignment of SarA,
SarR, SarS, and other SarA family members indicated that all of
these proteins likely belong to the same protein family. Second,
structural conservation among SarA family is very consistent,
based on the comparison of available structural information of
several family members. Third, the HTH motif and -hairpin
(wing) showed that the SarA protein family belongs to the very
well characterized superfamily of transcription factors called the
‘‘winged-helix’’ proteins. Based on potential interactions be-
tween the elongated -hairpin and minor groove of their target
DNAs, SarA and its homologs likely belong to a unique sub-
family of winged-helix proteins (18–19). Finally, we discovered
the same structure of SarA by using different crystallization
condition (see below). Thus, it seems unlikely that dramatic
conformational change occurs under unique crystallization con-
ditions for the SarA protein as has been suggested by other
authors (17).
The DNA-Binding Domains. Members of the winged-helix protein
family traditionally have very conserved DNA-binding motifs,
including the HTH and the winged region constituted by two
-sheets and an intervening loop (13). Modeling studies of SarR,
a SarA homolog, with promoter DNA also revealed that the
HTH and potential -hairpins (i.e., the winged region) on SarA
are involved in DNA interactions (18). Notably, the previously
reported structure of SarA with DNA by Schumacher et al. (17)
showed an unusual mode of interaction between protein and
DNA in which a bended 7-bp duplex DNA fragment with one
nucleotide 5 overhangs is held by residues that are not con-
served among members of the SarA protein family. In contrast
to the above studies, we did not detect any binding activity
between the 7-bp duplex DNA (AGTTAAG) (17, 22, 23) and the
SarA protein. To reexamine this issue, we mixed SarA protein
with the 7-bp DNA fragment for crystallization trials by follow-
ing the reported conditions in ref. 17. Crystals of the supposed
complex were obtained and diffracted beyond 3.0 Å at an
in-house x-ray resource with the same crystal forms as reported
in ref. 17. The structure was solved by a partial model (we just
used several helices that have correspondent ones in our SarA
structures to calculate the difference fouries) from the reported
complex structure in ref. 17. To our surprise, our SarA model has
a good fit in the additional electron density. However, we did not
observe any extra density of DNA fragment, with the assumed
DNA-binding location actually occupied by the SarA protein
Fig. 5. Effects of sarA mutations at codon positions 8 and 11 in in vivo and
in vitro expression of target genes. (A) Northern blots of RNA isolated from
S. aureus RN6390, isogenic sarA mutant ALC488, and ALC488 containing
shuttle plasmid with the wild-type and mutated sarA fragments and
probed with agr RNAII, spa or hla probe. (B) Western blots for intracellular,
secreted spent supernatant and cell-wall associated protein extracts were
probed with monoclonal anti-SarA antibody 1D1, polyclonal sheep anti-
-hemolysin antibody and affinity-purified chicken anti-protein A anti-
body, respectively. Equivalent amounts of extracts from the same growth
conditions were used to detect SarA and protein A expression, whereas
equal OD650 of spent cell culture supernatants were precipitated to detect
-hemolysin expression. Lanes are indentical to A. (C) Autoradiogram of an
8.0% nondenaturing gel showing gel-mobility shifts for increasing
amounts (0, 50, 100, and 300 ng) of purified wild-type and mutated SarA
proteins with a 180-bp agr P2-P3 promoter fragment (0.1 ng per reaction).









itself. Accordingly, we have determined the same SarA structure
with different crystallization conditions in the presence of a 7-bp
DNA fragment, but the DNA fragment was absent in the crystal
packing. Collectively, these data supported the notion that there
is only one form of SarA structure, and that form is a winged-
helix protein.
If our structure is correct, we speculate that SarA likely
interacts with DNA in a manner similar to other winged-helix
proteins such as SarR (18), with the HTH interacting with the
major groove and the ‘‘wing’’ with the minor groove of DNA.
Using this finding as a guide, we mutated conserved and, in
particular, basic residues within the HTH and the winged region
(see Fig. 3). Mutations of individual conserved residues (K54,
K63, K69, and L74) within HTH yielded proteins that were
expressed. The K54A and L74A mutant proteins bound less well
to the spa promoter, a target for SarA binding, than the K63A
and K69A proteins (11). These data suggested that more than
one residue in the HTH makes contact with the major groove of
DNA, and mutation of a single residue would only reduce, but
not abolish, binding to the target gene promoter. Whether
cooperative binding occurs among these residues is not clear. Of
interest is the finding that two basic residues within the HTH
(K63 and K69) conserved among many SarA family members did
not play a role in DNA binding.
Besides the HTH motif, we also mutated conserved and basic
residues within the winged region (Fig. 3). In examining these
and other conserved basic residues, it is interesting that only
basic residues R84 and R90 are critical to binding to the spa
promoter, whereas others, including K82A, have no effect.
Importantly, R84 and R90 are highly conserved within the
putative winged region among many SarA homologs (Fig. 3)
(13). Collectively, these data suggested that R84 and R90 are
important residues that make contact with target DNA among
the SarA protein family.
Structure and Function. Many of the mutations that led to reduced
binding, albeit moderately, to the spa promoter (Fig. 3) was
capable of complementing the sarA mutant, thus demonstrating
that a mild reduction in binding to the target promoter in vitro
would not translate to functional deficiency in vivo. As expected,
mutations that eventuated in defective binding proteins (R84A
and R90A) also failed to complement the sarA mutant (Fig. 4),
thus validating our gel-shift assay. Of interest, the acidic residues,
D88 and E89, adjacent to the basic DNA-binding residue R90
and highly conserved in the ‘‘wing’’ region among members of
the winged helix family (13), displayed normal binding to the spa
promoter but were not functional with respect to complemen-
tation. These data thus demonstrated the DER residues within
SarA and possibly the winged helix family are critical for both
DNA binding and activation. Further high-resolution structures
of the protein–DNA complex may plausibly explain how three
contiguous residues in the winged region could have important
roles in both DNA binding and function.
As with the SarR protein, SarA also has a concave side and a
convex side. Previous studies on SarR have suggested the
DNA-binding surface to reside on the concave side, whereas the
putative activation motifs are located on the convex side (18).
Based on the location of the acidic residues on SarR, we
predicted D8 and E11 of SarA to represent an activation domain.
Curiously, the crystal structure of SarA also predicted the role
of E8 and E11 in connecting two dimers via a divalent cation
bridge (Fig. 2). The notion of a SarA multimer in binding to
DNA was also supported by results of gel-retardation assays,
showing a large mobility shift of the protein–DNA complex (9,
11, 12, 22–24). It will be of interest to understand how these
multiple homodimers bind to their target DNA and their asso-
ciation with each other. The current SarA structure and their
association with divalent cations seem to reveal a potential
association of multiple homodimers. However, the exact number
of dimers is not clear. The data by Rechtin et al. (23) indicated
that three homodimers of SarA might be a reasonable estimate.
To address the importance of the divalent cation-binding sites on
SarA, D8 and E11 were both mutated to alanine. Contrary to the
wild-type gene, the D8A-E11A mutant did not complement the
sarA mutant phenotype (Fig. 4), even though the mutant D8A-
E11A protein bound comparably to the target agr promoter vs.
the wild-type protein. Thus, D8 and E11 are not involved in DNA
binding but are necessary for activation. Combining all these
available data, one potential regulation scenario would be that,
in the absence of divalent cations, multiple SarA dimers (with the
major site occupied by the first SarA dimer, which could
cooperatively bring more SarA into minor binding sites) bind to
the promoter region of the target gene, but the repulsive force
conferred by the negative charge of two acidic residues (Asp-8
and Glu-11) coerce the SarA dimers to work independently to
bend and shorten the target DNA to position the RNA poly-
merase into a proper initiation state. However, the introduction
of divalent cations at the proper site will facilitate the juxtapo-
sition of two SarA homodimers. This cation-mediated interac-
tion could encourage shortening of the promoter DNA and,
hence, proper engagementdisengagement of RNA polymerase
on the promoter. An additional but untested possibility is that
SarA may stabilize some RNA transcripts and potentially pro-
mote specific gene expression.
Methods
Protein Expression, Purification, and Crystallization. Protein expres-
sion and purification followed the procedure as described in ref.
11. Crystals for SarA protein (15 mgml) was crystallized by
vapor diffusion against a solution of 200 mM calcium acetate
100 mM sodium cacodylate, pH 6.5)20% PEG 8000 at room
temperature. Heavy-atom derivatives were prepared by soaking
crystals for 24 h in 1 mM HgCl2, which was dissolved in the
crystallization solution. Crystals of SarA were transferred to
crystallization buffer with 20% glycerol25% PEG 8000 for a
half hour before flash-freezing. The second crystal of the SarA
protein in the presence of a short DNA fragment was obtained
as reported in ref. 17.
Structure Determination and Refinement. SarA crystals belong
to space group P6122 with cell dimension of 65.34 Å  65.34 Å 
237.29 Å and one dimer per asymmetric unit. The native data set
was collected at CHESS. The HgCl2 derivative data were
collected at Advanced Light Source (Table 1, which is published
as supporting information on the PNAS web site). All data were
processed with DENZO and SCALEPACK (25). Initial single iso-
morphous replacement (SIR) phases were derived from SOLVE
(26) and improved by SOLOMON (27). Model building was carried
out in O (28) with the help of SarR model (18). The electron
density at ‘‘W1’’ regions was poor from the initial SIR and
solvent flattening map, most of these regions showed up in the
2Fc  Fo and Fc  Fo omit maps, nevertheless, some side chains
are partially ordered. The model was refined by CNS (29)
constrained with one noncrystallographic symmetry operator.
Two half Ca2 showed up in the Fc  Fo map with eight sigma
peaks and were in the final refinement (Fig. 8). No water has
been added at current resolution. The final model contains all
residues of SarA. The coordinates have been submitted to the
Brookhaven Protein Data Bank as entry 2FRH. The structure of
the second crystal of the SarA protein was determined by the
Difference Fouriers by using three -helices from the published
SarA structure (17) as initial model. A refined model SarA from
this crystal form also has been deposited with PDB ID 2FNP.
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Site-Directed Mutagenesis and Northern and Western Blots Analysis.
Site-directed mutagenesis was performed with the Muta-Gene
in vitro mutagenesis kit (Bio-Rad) to introduce mutations into
the sarA gene as described in the manufacturer’s insert. A 650-bp
sarA P1 fragment containing the sarA gene was used as the
template for mutation. Various primers were designed to intro-
duce mutation at D8, C9, E11, Y18, K21, K23, K27, K28, E29,
E36, L40, K54, K63, K69, L74, F80, K82, R84, D88, E89, R90,
Q100, and I104 codon positions of SarA to yield various SarA
mutant proteins with alanine at corresponding positions. The
fragments containing mutations were gel-purified, ligated into
shuttle plasmid pSK236 (ampr for E. coli and Cmr for S. aureus),
and transformed E. coli XL-1 Blue strain. The authenticity of the
recombinant constructs was confirmed by DNA sequencing. S.
aureus RN4220 was used as the initial recipient for the correct
recombinant constructs. Plasmid constructs from RN4220 were
reintroduced into sarA mutant (ALC488) as described in ref. 30.
Northern blot analysis was performed as described in ref. 30
to assess the transcription of sarA and sarA-regulated target
genes during exponential and postexponential phases in mutant
strains containing the sarA gene with mutations at the various
codon positions as described earlier. Western blots analysis of
cell extract proteins from postexponentially grown cells was used
to detect SarA expression. Five micrograms of total cell protein
extracts from each sample were electrophoresed and blotted
onto nitrocellulose membrane. The immunoblots were probed
with monoclonal anti-SarA antibody 1D1 to detect the expres-
sion of SarA (30).
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